Catalyst Wire Dossier Catalyst Wire Dossier

Aleglitazar

Aleglitazar · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

21 regulatory and trial events tracked for Aleglitazar, covering 2012-05-22 to 2017-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone [Phase 3]

See pricing